Shik79
$IFRX Short term, I’m as frustrated as most here. But this is how this stock moves. The tape since the May peak:
1. Rallies are news-driven and heavy: +14%, +19%, +20% and +10% days, each on 2–6x normal volume.
2. Declines are mostly quiet: 12 of 18 drops of 5%+ came on below-average volume (−7.6% on 284k shares, −5.6% on 221k). That’s missing buyers, not dumping.
3. The CMD was the one real repricing: −26% in 4 days on 10.3M shares, 7x normal on day one.
4. Supply sits at $2.33–2.65, above the $2.00 offering. Every rally culminated there.
Outside CMD week, the tape shows no dump, just a drift on thin volume to at or below net cash (~$1.13–1.17/sh). With buyers absent, real news (FDA endpoint alignment, a China deal, aHUS data, a Tavneos ruling) can move this +40% in two weeks, as it did three times this year. Early-Dec 13G/As will show whether the big holders stayed.
12

:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault41.jpg)
:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault28.jpg)